Protect Our Care to Urge Senator Menendez to Support Medicare Negotiations to Bring Down Drug Prices With Mobile Billboard with Advocates Outside of Jersey City Office

9 Out Of 10 New Jersey Voters Support Allowing Medicare To Negotiate; 78% Think Drug Prices Are Unreasonable

Jersey City, NJ — A mobile billboard and event with constituents sponsored by Protect Our Care will appear in front of U.S. Senator Bob Menendez’s (D-NJ) Jersey City office on Tuesday, October 5, calling on the senator to stand up to Big Pharma and bring relief to New Jersey’s seniors and families who struggle to afford their medications. The mobile billboard will be circling his office at 11:00AM EST, and it will join constituents and advocates who are urging the senator to support Medicare negotiations to lower drug prices on prescription drugs.

These actions come as Congress is closing in on a budget agreement that will transform the lives of American families nationwide. President Biden and Democrats are leading the charge to include Medicare negotiation and other key health care priorities in the Build Back Better package, but the fight is not over: Big Pharma is ramping up its lobbying and scare tactics to protect its profits and lie to the American people. This event will make clear that Senator Menendez must not cower to the demands of drug companies and deliver on her promises to her constituents and all Americans. 

Event Details:

Protect Our Care
Concerned Citizens

WHAT: Protect Our Care to Urge Senator Menendez to Support Medicare Negotiations and Bring Down Drug Prices With Mobile Billboard and Protest District Office

WHERE: 210 Hudson Street, Harborside 3, Jersey City, NJ 07302

WHEN: Tuesday October 5 at 11:00 AM EST

The mobile billboard outside Senator Menendez’s district office comes on the heels of a new polling project showing the overwhelming, bipartisan support for this reform across New Jersey. With this project and interactive map, Senator Menendez and his constituents can now find the level of backing for Medicare negotiation, opinions about pharmaceutical companies, concerns about Congress failing to act, and belief in pharma’s top arguments. The project was conducted by Data for Progress on behalf of Protect Our Care and Patients For Affordable Drugs Now.